Metastatic differentiated thyroid carcinoma: Clinical management and outcome of disease in patients with initial and late distant metastases

Nuclear Medicine Communications

Volumn 30, Issue 7, 2009, Pages 558-564

  Mihailovic, Jasna M ^a   Stefanovic, Ljubomir J ^a   Malesevic, Milica D ^a   Erak, Marko D ^a   Tesanovic, Dusanka D ^a  

^a ONCOLOGY INSTITUTE OF VOJVODINA   (Serbia)

Author keywords

Differentiated thyroid carcinoma; Disease related deaths; Disease specific survival; Distant metastases; Late distant metastases; Metastases at presentation; Outcome of disease

Indexed keywords

ANTINEOPLASTIC AGENT; IODINE 131; LEVOTHYROXINE;

ADULT; ARTICLE; BONE METASTASIS; CALCULATION; CANCER SURVIVAL; CONTROLLED STUDY; DEATH; DISTANT METASTASIS; FEMALE; FOLLICULAR CARCINOMA; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAPILLARY CARCINOMA; PROBABILITY; REMISSION; RISK; SEX; STUDENT T TEST; THYROID CARCINOMA;

AGE FACTORS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67650308598     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32832cc2ab     Document Type: Article

References (29)

1. Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. 2007 Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metasasis at diagnosis. Cancer 2007; 110:1451-1456.
2. Shaha AR, Shah JP, Loree TR. Differentiated thyroid cancer presenting initially with distant metasrtasis. Am J Surg 1997; 174:474-476.
3. Muresan MM, Olivier P, Leclere J, Sirveaux F, Brunaud L, Klein M, et al. Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer 2008; 15:37-49.
4. Shoup M, Stojadinovic A, Nissan A, Ghossein RA, Freedman S, Brennan MF, et al. Prognostic Indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 2003; 197:191-197.
5. Samaan NA, Maheshwari YK, Nader S, Hill CS Jr, Schultz PN, Haynie TP, et al. Impact of therapy for differentiated carcinoma of the thyroid: analysis of 706 cases. J Clin Endocrinol Metab 1983; 56:1131-1138.
6. Ruegemer JJ, Hay ID, Bergstarlh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metasatsis in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988; 67:501-508.
7. Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986; 63:960-967.
8. Brown AP, Greening WP, McCready VR, Shaw HJ, Harmer CL. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984; 57:323-327.
9. Brink JS, van Heerden JA, McIver B, Salomao DR, Farley DR, Grant CS, et al. Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery 2001; 128:881-887.
10. La Quaglia MP, Black T, Holcomb GW, Sklar C, Azizkhan RG, Haase GM, et al. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients with distant metastases. A report from the surgical discipline committee of the children's cancer group. J Pediatr Surg 2000; 35:955-960.
11. Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol 2005; 63:87-93.
12. Stefanovic Lj, Guduric B, Sljapic N, Babic J, Miljkovic Lj, Malesevic M, et al. Protocols of diagnostics, treatment and control of malignant thyroid tumors at the Institute of oncology in Sremska Kamenica. Onc Arch 1994; 2:101-107. (Serb)
13. Sobin LH, Wittekind CH. TNM classification of malignant tumours. 6th ed. New Jersey, USA: John Wiley & Sons; 2002.
14. Brierley J, Tsang R, Panzarella T, Bana N. Prognostic factors and the effect of treatment with radioactive iodine and external radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf) 2005; 63:418-427.
15. Mihailovic J, Stefanovic LJ, Malesevic M. Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors. Cancer Biother Radipharm 2007; 22:250-255.
16. Sugitani I, Fujimoto Y, Yamamoto N. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 2008; 143:35-42.
17. Stefanovic LJ, Vojicic J, Malesevic M, Mihailovic J, Srbovan D. Treatment outcome in patients with differentiated thyroid carcinoma and distant metastases. J BUON 2001; 6:263-269.
18. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006; 91:2892-2899.
19. Lin J-D, Huang M-J, Juang J-H, Chao T-C, Huang B-Y, Chen K-W, et al. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid 1999; 9:1227-1235.
20. Dietlein M, Moka D, Shicha H. Radioiodine therapy for thyroid cancer. In: Biersack HJ, Grunwald F, editors. Thyroid cancer. 2nd ed. Berlin Heidelberg: Springer-Verlag; 2005. pp. 95-126.
21. Pomorski L, Bartos M. Metastasis as the first sign of thyroid cancer. Neoplasma 1999; 46:309-312.
22. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996; 37:598-605.
23. Massin JP, Savoie JC, Garnier H, Guiraudon G, Leger FA, Bacourt F. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer 1984; 53:982-992.
24. Nemec J, Zamrazil V, Pohunkova D, Rohling S. Radioiodine treatment of pulmonary metastases of differentiated thyroid cancer. Results and prognostic factors. Nuklearmedizin 1979; 18:86-90.
25. Dinneen S, Valimaki M, Bergstralh E, Goellner J, Gorman C, Hay ID. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995; 80:2041-2045.
26. Decaussin M, Bernard MH, Adeleine P, Treilleux I, Peix JL, Pugeat M, et al. Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular component. Am J Surg Pathol 2002; 26:1007-1015.
27. Zetting G, Fueger BJ, Passler C, Kaserer K, Pirich C, Dudczak R, et al. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma-surgery or conventional therapy? Clin Endocrinol (Oxf) 2002; 56:377-382.
28. Mizukami Y, Michigishi T, Nonomura A, Hashimoto T, Terahata S, Noguchi M, et al. Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study. Human Pathology 1990; 21:283-290.
29. Smith SA, Hay ID, Goellner JR, McConahey WM. Mortality from papillary thyroid carcinoma. A case-control study of 56 lethal cases. Cancer 1988; 62:1381-1388.